Clinical Trial

iCorMicA - Stratified Medicine in Angina

Study acronym: iCorMicA
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 9, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The iCorMicA study is a multicentre, prospective, randomised, double-blind, sham-controlled, parallel-group, end-point trial and registry. The investigators seek to determine whether stratified medical therapy guided by an adjunctive interventional diagnostic procedure (IDP) during the invasive management of patients with known or suspected angina but no obstructive coronary artery disease improves symptoms, wellbeing, cardiovascular risk and clinical outcomes.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2020-12-17; most recent amendment 2026-04-03.
Status change: Not Yet Recruiting → Recruiting 2020-12-27
Trial Details
NCT Number NCT04674449
Lead Sponsor NHS Greater Glasgow and Clyde
Collaborators: University of Glasgow, Abbott Medical Devices
Conditions Microvascular Angina, Angina, Stable, Ischemia With No Obstructive Coronary Arteries (INOCA), Coronary Microvascular Dysfunction (CMD), Ischaemic Heart Disease, Non-Obstructive Coronary Atherosclerosis, Coronary Artery Disease, Vasospastic Angina +2 more
Enrollment 1,500 participants
Start Date 2020-12-30
Primary Completion 2026-06-30 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-09